S. Eva Singletary
The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Breast Implant and Reconstruction, BRCA gene mutations in cancer, Cancer Treatment and Pharmacology
Most-Cited Works
- → Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy(2007)1,627 cited
- → Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy(1999)1,334 cited
- → Revision of the American Joint Committee on Cancer Staging System for Breast Cancer(2002)1,182 cited
- → Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer(2005)1,165 cited
- → Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology(2000)1,025 cited
- → Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy(2002)612 cited
- → Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen(2007)467 cited
- → Management of Breast Cancer During Pregnancy Using a Standardized Protocol(1999)426 cited
- → Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy(2005)421 cited
- → Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience(2004)407 cited